Prescribing Information| For US Healthcare Professionals

Text Size

Let’s get the word out about meningitis B

We send our kids out into the world, full of hope. And we don't want something like meningitis B getting in their way.
WATCH VIDEO

Not an actual group.
For illustrative purposes only.

BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B. BEXSERO is approved for use in individuals 10 through 25 years of age.

Approval of BEXSERO is based on demonstration of immune response against three serogroup B strains representative of prevalent strains in the United States. The effectiveness of BEXSERO against diverse serogroup B strains has not been confirmed.

BEXSERO may not protect all individuals.

BEXSERO is the ONLY
meningitis B vaccine
that can
be completed in as fast as
1 month with just 2 doses

Help protect your teen against meningitis B.

Talk to your healthcare professional about vaccination with BEXSERO.

FIND OUT WHERE TO GET BEXSERO

More than 90% of 16- to 23-year-olds have not been vaccinated against meningitis B*

*Data as of January 2017.

The meningitis vaccine most people may have received when they were younger covered meningitis ACWY, not meningitis B. That's because a meningitis B vaccine wasn't available until 2014.

BEXSERO is a vaccine approved to help prevent meningitis B.

Although meningitis B is uncommon,
it's not a chance you want to take

Increased
risk.

16- to 23-year-olds are at an increased risk of getting meningitis B

Uncommon but can be fatal.

About 1 in 10 people infected with meningitis B will die, sometimes within hours

Sudden & unpredictable.

Meningitis B strikes quickly - usually without warning

MORE ABOUT MENINGITIS B

Need a reminder for your BEXSERO appointment?

Sign up for GSK's Vaccine Reminder Service for MenB.You'll get a text message reminder the day before your BEXSERO appointment.

GET TEXT REMINDER

Important Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions in latex-sensitive individuals

Important Safety Information About BEXSEROImportant Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions in latex-sensitive individuals
  • Tell your healthcare professional if you are pregnant, plan to become pregnant, or are breastfeeding
  • Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare professional may ask you to sit or lie down for 15 minutes after receiving BEXSERO
  • The most common side effects are pain, redness or hardness at the injection site; muscle pain; fatigue; headache; nausea; and joint pain
  • Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
  • Vaccination with BEXSERO may not result in protection in all vaccine recipients
  • Ask your healthcare professional about the risks and benefits of BEXSERO. Only a healthcare professional can decide if BEXSERO is right for you or your child